TITLE

Apitope Raises €10M for its MS Drug Phase II Trial

PUB. DATE
November 2008
SOURCE
Bioworld Week;11/3/2008, Vol. 16 Issue 44, p4
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports that Apitope Ltd. has raised €10 million from Belgian investors to carry out its Phase II proof-of-concept trial of peptide-based immunotherapy for multiple sclerosis. This move is part of the firm's formal venture capital funding round. The spur to put together the Belgian syndicate is an approach to Apitope from the University of Hasselt. The money will also be used to advance the firm's second product, a hemophilia treatment.
ACCESSION #
35064708

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics